Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza.

JCI insight(2023)

引用 0|浏览22
暂无评分
摘要
gov NCT02287467FUNDING SOURCES. Funding for this research was provided by Subcontract 13XS134 under Leidos Biomedical Research Prime Contract HHSN261200800001E and HHSN261201500003I, NCI/NIAID.
更多
查看译文
关键词
severe human anti-influenza,hyperimmune,treatment benefit,flu-ivig
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要